case / 18 Apr 2024

Setterwalls advises BrainCool in connection with a rights issue

Responsive image
Setterwalls advises BrainCool AB (publ), listed on Nasdaq First North Growth Market, in connection with a rights issue of shares.
BrainCool is an innovative medical technology company that develops, markets and sells leading medical cooling systems for indications and areas with significant medical added value in healthcare. BrainCool is headquartered in Lund, Sweden. Through the rights issue, BrainCool may receive issue proceeds of approximately SEK 85.8 million before issue costs.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

  • This field is for validation purposes and should be left unchanged.